Press Release
1 July 2024
Croda appoints Chief Financial Officer
Croda International Plc, the company that uses smart science to create ingredients and technologies that improve lives, today announces that the Board has appointed Stephen Oxley as Chief Financial Officer (CFO) and Executive Director.
Stephen, a qualified accountant, is currently CFO of Johnson Matthey Plc, the specialty chemicals and sustainable technologies company. Stephen brings valuable experience in strategy setting and execution, enhancing business performance, transformation and corporate transactions.
Stephen was previously a Partner at KPMG where he spent nearly 30 years advising global companies across consumer, healthcare and industrial sectors. He is also a Non-Executive Member of the Audit and Risk Committee for the Sovereign Grant which oversees the UK's public grant to the Royal Family.
Stephen will join Croda no later than 1 April 2025 following a notice period. Anthony Fitzpatrick, President Strategy, Corporate Development & Industrial Specialties, has been appointed Interim Chief Financial Officer. Anthony joined Croda and the Executive Committee in 2014 having previously spent more than 20 years in global investment banking.
Commenting, Danuta Gray, Croda Chair, said:
"I am delighted that Stephen Oxley is joining as CFO. Alongside his strong track record as a PLC Chief Financial Officer incorporating strategic thinking and operational delivery, he brings valuable experience of audit and advisory roles for large, complex international companies across a number of relevant sectors during his time as a Partner at KPMG. I look forward to welcoming him to the Board.
"Anthony Fitzpatrick has a deep understanding of Croda and we are pleased that he has agreed to act as CFO on an interim basis before helping to oversee an orderly handover to Stephen when he joins early next year."
There are no further details required to be disclosed under Listing Rule 9.6.13R.
For enquiries contact:
Investors: David Bishop, Croda +44 7823 874 428
Media: Charlie Armitstead, FTI Consulting +44 7974 278 280
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
